Schedule 13G ownership disclosure

SIGA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 826917106

Event date: 2022-06-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,634,392
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-074298
Form type
SC 13G
Filer
D. E. SHAW & CO, L.P.
CIK
CIK 1009268
Filed
Jun 24, 2022
Reporting period
Jun 14, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub